EP0910378A4 - Verfahren zur steigerung der sphinktereffektivität - Google Patents

Verfahren zur steigerung der sphinktereffektivität

Info

Publication number
EP0910378A4
EP0910378A4 EP97903959A EP97903959A EP0910378A4 EP 0910378 A4 EP0910378 A4 EP 0910378A4 EP 97903959 A EP97903959 A EP 97903959A EP 97903959 A EP97903959 A EP 97903959A EP 0910378 A4 EP0910378 A4 EP 0910378A4
Authority
EP
European Patent Office
Prior art keywords
methods
sphincter competence
increasing sphincter
increasing
competence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97903959A
Other languages
English (en)
French (fr)
Other versions
EP0910378A1 (de
Inventor
George J Cullinan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603147.1A external-priority patent/GB9603147D0/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP0910378A1 publication Critical patent/EP0910378A1/de
Publication of EP0910378A4 publication Critical patent/EP0910378A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP97903959A 1996-01-29 1997-01-27 Verfahren zur steigerung der sphinktereffektivität Withdrawn EP0910378A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1077196P 1996-01-29 1996-01-29
US10771P 1996-01-29
GB9603147 1996-02-15
GBGB9603147.1A GB9603147D0 (en) 1996-02-15 1996-02-15 Methods of increasing sphincter competence
PCT/US1997/001159 WO1997026876A1 (en) 1996-01-29 1997-01-27 Methods of increasing sphincter competence

Publications (2)

Publication Number Publication Date
EP0910378A1 EP0910378A1 (de) 1999-04-28
EP0910378A4 true EP0910378A4 (de) 1999-06-23

Family

ID=26308706

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97903959A Withdrawn EP0910378A4 (de) 1996-01-29 1997-01-27 Verfahren zur steigerung der sphinktereffektivität

Country Status (11)

Country Link
EP (1) EP0910378A4 (de)
JP (1) JP2000503991A (de)
CN (1) CN1213303A (de)
AU (1) AU732473B2 (de)
CZ (1) CZ235598A3 (de)
EA (1) EA001103B1 (de)
HU (1) HUP9903440A3 (de)
IL (1) IL125522A0 (de)
NO (1) NO983453L (de)
NZ (1) NZ331085A (de)
WO (1) WO1997026876A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1113007A1 (de) 1999-12-24 2001-07-04 Pfizer Inc. Tetrahydroisochinolin-Verbindungen zur Verwendung als Östrogen-Agonisten/-Antagonisten
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
WO2002003989A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating sphincter incontinence
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
US20040248989A1 (en) 2003-06-05 2004-12-09 Risto Santti Method for the treatment or prevention of lower urinary tract symptoms
JP5123935B2 (ja) 2006-05-22 2013-01-23 ホルモス メディカル リミテッド 選択的エストロゲン受容体モジュレーターまたはアロマターゼ阻害剤を用いた慢性非細菌性前立腺炎の治療方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652001A1 (de) * 1993-10-15 1995-05-10 Eli Lilly And Company Behandlung Peri-menopausaler Syndrome
WO1997025984A1 (en) * 1996-01-18 1997-07-24 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492927A (en) * 1993-12-21 1996-02-20 Eli Lilly And Company Non-peptide tachykinin receptor antagonists to treat allergy
US6562862B1 (en) * 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
AU3899595A (en) * 1994-12-02 1996-06-19 Mostyn Farmer Golf stance training aid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652001A1 (de) * 1993-10-15 1995-05-10 Eli Lilly And Company Behandlung Peri-menopausaler Syndrome
WO1997025984A1 (en) * 1996-01-18 1997-07-24 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CARDOZO L ET AL: "SEX HORMONES AND THE FEMALE LOWER URINARY TRACT", PHYSIOTHERAPY, vol. 80, no. 3, March 1994 (1994-03-01), pages 135 - 138, XP000670049 *
See also references of WO9726876A1 *

Also Published As

Publication number Publication date
IL125522A0 (en) 1999-03-12
WO1997026876A1 (en) 1997-07-31
NO983453D0 (no) 1998-07-27
EP0910378A1 (de) 1999-04-28
CZ235598A3 (cs) 1999-03-17
AU1838697A (en) 1997-08-20
NZ331085A (en) 2000-06-23
AU732473B2 (en) 2001-04-26
HUP9903440A3 (en) 2000-07-28
HUP9903440A2 (hu) 2000-06-28
EA199800676A1 (ru) 1999-02-25
CN1213303A (zh) 1999-04-07
EA001103B1 (ru) 2000-10-30
JP2000503991A (ja) 2000-04-04
NO983453L (no) 1998-09-11

Similar Documents

Publication Publication Date Title
PL330990A1 (en) Improved method of halogenating isomo-olefinic copolymers
PL331771A1 (en) Method of improving seeds
PL333364A1 (en) Novel compounds and method of using them
IL125829A0 (en) Method of sharing cryptokey
EP0914115A4 (de) Neuroprotektive methoden
PL318452A1 (en) Method of obtaining peroxyperfluoropolyoxyalkylenes
EP1017459A4 (de) Glücksspiel
PL330400A1 (en) Method of obtaining azacyclohexapeptides
HU9702480D0 (en) New polymorphe modification of doxazosin-mesylate
IL125522A0 (en) Methods of increasing sphincter competence
PL332077A1 (en) Method of obtaining omepraole
GB9602704D0 (en) Structure of perculator
CY2590B2 (en) Preparation of 1-butyl-4-piperidinylmethylamine
HU9702479D0 (en) New polymorphe modification of doxazosin-mesylate
PL313419A1 (en) Method of obtaining beta-naphtole
PL333977A1 (en) Method of obtaining benzisothiazolyn-3-ones
PL321479A1 (en) Method of polymerising isocyanatges
PL328082A1 (en) Method of improving sphincter competence
GB9603147D0 (en) Methods of increasing sphincter competence
GB9616563D0 (en) Compounds and methods
GB2317119B (en) Educational system of shapes
PL317788A1 (en) Method of obtaining 3-isocyanate-propylsilane
PL332075A1 (en) Method of obtaining nizathidine
EP0934345A4 (de) Verbindungen und verfahren
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980727

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 19980727;LT PAYMENT 19980727;LV PAYMENT 19980727;RO PAYMENT 19980727;SI PAYMENT 19980727

RIC1 Information provided on ipc code assigned before grant

Free format text: 6A 61K 31/445 A

A4 Supplementary search report drawn up and despatched

Effective date: 19990510

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 20001030

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040827